- Investing Ideas
- /
- Swedish Undervalued Stocks Based On Cash Flows
Swedish Undervalued Stocks Based On Cash Flows
UPDATED May 18, 2024
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
141 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
XBRANE | kr0.20 | -12.0% | -99.8% | kr309.0m | n/a | PS1.6x | E105.2% | n/a | Pharmaceuticals & Biotech | ||
CLBIO | kr10.50 | 4.0% | -35.0% | kr225.7m | kr29.00 | PS7.3x | E114.8% | n/a | Pharmaceuticals & Biotech | ||
CALTX | kr117.20 | 5.8% | 13.8% | kr6.3b | kr208.00 | PS5.2x | E49.9% | n/a | Pharmaceuticals & Biotech | ||
SPAGO | kr0.27 | -11.4% | -66.5% | kr59.5m | n/a | PS10x | E52.1% | n/a | Pharmaceuticals & Biotech | ||
KLAR | kr0.44 | 12.3% | 2.1% | kr46.8m | kr1.00 | PB1.6x | E61.3% | n/a | Pharmaceuticals & Biotech | ||
ECC B | kr2.78 | -15.5% | -39.7% | kr128.5m | kr8.50 | PB0.5x | E77.3% | n/a | Capital Goods | ||
ORX | kr21.15 | 9.8% | 101.0% | kr728.6m | kr24.00 | PS1.2x | E77.5% | n/a | Pharmaceuticals & Biotech | ||
EGTX | kr7.00 | 11.6% | -10.1% | kr2.0b | kr14.30 | PS32.6x | E98.4% | n/a | Pharmaceuticals & Biotech | ||
DIGN | kr1.51 | 0% | -61.5% | kr106.1m | kr8.60 | PS1.2x | E139.0% | n/a | Healthcare | ||
SGG | kr78.30 | 0.1% | 17.9% | kr902.8m | kr110.00 | PE44.1x | E52.7% | n/a | Tech | ||
MAHA A | kr8.63 | 1.4% | -3.8% | kr1.5b | kr12.75 | PS36.3x | E55.0% | n/a | Energy | ||
SUN4 | kr6.06 | -3.5% | -47.4% | kr120.4m | kr9.50 | PE15.6x | E61.3% | n/a | Capital Goods | ||
VERT B | kr42.70 | -2.7% | 53.0% | kr875.4m | kr50.00 | PE43.1x | E26.9% | 0% | Software | ||
SENZA | kr9.32 | -1.5% | -19.7% | kr225.4m | kr17.75 | PS4.3x | E95.4% | n/a | Pharmaceuticals & Biotech | ||
ACROUD | kr0.87 | -6.3% | -56.3% | kr149.5m | kr1.90 | PB5.4x | E101.7% | n/a | Consumer Services | ||
OVZON | kr18.46 | 16.8% | -42.7% | kr2.1b | kr11.50 | PS6.6x | E91.3% | n/a | Telecom | ||
DVYSR | kr99.80 | 0% | 23.5% | kr1.6b | kr126.15 | PS9x | E99.0% | n/a | Pharmaceuticals & Biotech | ||
NEWBRY | kr3.10 | -5.2% | -44.4% | kr75.2m | kr8.00 | PS3.3x | E112.9% | n/a | Pharmaceuticals & Biotech | ||
NOHARM | kr0.15 | 10.1% | -53.7% | kr44.7m | n/a | PB1x | E121.6% | n/a | Food, Beverage & Tobacco | ||
MEDHLP | kr3.04 | -5.0% | -17.8% | kr92.5m | n/a | PS1x | E87.4% | n/a | Healthcare | ||
CANDLE B | kr23.60 | -3.7% | -29.6% | kr204.2m | kr42.00 | PS1.2x | E125.3% | n/a | Consumer Durables | ||
SKOLON | kr21.50 | 2.4% | -21.8% | kr570.7m | kr27.50 | PE83.8x | E67.4% | 2.6% | Software | ||
CLEM | kr0.94 | 2.4% | -12.1% | kr130.2m | kr1.45 | PE13.1x | E22.3% | 0% | Household | ||
W5 | kr72.70 | -0.4% | -22.7% | kr1.1b | kr104.00 | PS2.6x | E83.0% | n/a | Capital Goods |